Selection of human adenovirus serotypes with no affinity to human RBCs.

Selection of human adenovirus serotypes with no affinity to human RBCs.

<p><b>(A)</b> Schematic representation of the selection from wild-type adenovirus 11 (Group <b>B)</b>, adenovirus 5 (Group <b>C)</b>, and adenovirus 26, 28, and 51 (Group D) in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.032...

Descrición completa

Gardado en:

Detalles Bibliográficos
Autor Principal:	Masahisa Hemmi (21601907) (author)
Outros autores:	Midori Yamashita (21601910) (author), Yoshiko Shimizu (171960) (author), Shinsuke Nakao (52048) (author)
Publicado:	2025
Subjects:	Medicine Cell Biology Molecular Biology Pharmacology Biotechnology Ecology Immunology Cancer Mental Health Hematology Infectious Diseases Virology Chemical Sciences not elsewhere classified shown clinical benefit promising therapeutic approach minimum binding affinity ad11 antibody clones killing cancer cells cancer cells inhibit binding cancer types cancer treatment vec ), unique modality talimogene laherparepvec several limitations selectively replicate prevent use oncolytic viruses natural receptor multifaceted mechanisms intravenous administration intratumoral administration human erythrocytes ensuring safe class agent broader range advanced melanoma ad11 fibers
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!